Dividend

Medicalgorithmics SA, in accordance with the adopted dividend policy, provides for regular dividend payments to shareholders.

Each time, the specific value of the dividend and the date of determining the right to dividend and the date of its payment are determined by the General Meeting of Shareholders after prior recommendation of the Management Board.

Dividend payment history

Fiscal yearDividend per shareDividend sizeDividend dayPayday
20171.42 PLN5 212 thousand PLNJuly 16, 2018July 30, 2018
20162.00 PLN7 213 thousand PLNJuly 16, 2017July 30, 2018
20151.85 PLN6,392 thousand PLNJuly 8, 2016July 25, 2016
20141.60 PLN5,528 thousand PLNJuly 7, 2015September 28, 2015
20131.35 PLN4,664 thousand PLNJuly 4, 2014August 19, 2014
20121.10 PLN3,764 thousand PLNJuly 4, 2013August 19, 2013

Dividend payment history

The Dividend Policy of Medicalgorithmics SA is an element of ensuring a balance between the amount of dividends paid out and the possibilities of effective investment of the funds generated by the Company. The recommendation of the Management Board regarding the dividend payment policy was included in the resolution of the Management Board No. 3/05/2017 of May 29, 2017, it was positively reviewed by the Supervisory Board of the Company under resolution No. 2 of the Supervisory Board of June 1, 2017.

  1. Subject to section 2, 3 and 4 below, the intention of the Management Board is that the dividend payments from the profit earned by the Company for the financial years following the financial year 2016 should be set at the level of up to 50% of the consolidated net profit of the Medicalgorithmics Capital Group, attributable to the shareholders of the parent company for the given financial year based on the consolidated financial statements and allocating the remaining part of the profit to supplementary capital;

  2. In the case of actual or anticipated capital needs of the Company of significant value, the Management Board’s recommendations regarding the payment of dividends from the profit generated by the Company for the financial years 2017, 2018 or 2019 may be set at the level of up to 20% of the consolidated net profit of the Medicalgorithmics Capital Group, attributable to the shareholders of the parent company for a given financial year on the basis of the consolidated financial statements and allocating the remaining part of the profit to supplementary capital;

  3. Due to the content of the terms of issue of securities issued by the Company, in particular bonds, the possibility of allocating the Company’s net profit shown in the Company’s financial statements for the given financial year 2017, 2018 or 2019 for the payment of dividend may be excluded or limited;

  4. The final recommendation of the Management Board regarding the distribution of the profit generated in the Capital Group will be affected by the market, financial and liquidity situation of the Group, existing and future liabilities and related provisions regarding not exceeding a certain level of debt;

  5. The Management Board will recommend the dates according to which the list of shareholders entitled to dividend payments and the dividend payment dates are determined, taking into account the need to carry out this process efficiently. The final decision on the distribution of the Company’s net profit for the financial year 2016 and for subsequent financial years will be taken by the Ordinary General Meeting of Shareholders of the Company.
   

Legal rules for determining
the payment of dividends

The dividend is paid to the shareholders once a year after the end of the financial year on the basis of a resolution of the Ordinary General Meeting on the allocation of the profit to be paid to the shareholders. Medicalgorithmics SA shares are not privileged as to the dividend. This means that each share has the same value of the dividend paid out.

Information on the dividend payment of Medicalgorithmics SA is announced in the form of current reports. The right to dividend is vested in investors whose accounts will contain shares of Medicalgorithmics SA on the dividend day.


Pursuant to Art. 395 § 2 item 2 of the Code of Commercial Companies, the body competent to make decisions on profit distribution and dividend payment is the General Meeting. The General Meeting adopts a resolution on whether and what part of the profit should be allocated to the payment of dividends. The profit distribution proposal approved by the Supervisory Board is presented to the Ordinary General Meeting by the Management Board. According to Art. 395 § 1 of the Code of Commercial Companies, the Ordinary General Meeting should be held within six months after the end of the financial year.


Art. 348 § 3 of the Code of Commercial Companies stipulates that the General Meeting of a public company sets the dividend date, i.e. the date of establishing the right to dividend and the date of dividend payment. The dividend day may be set on the day of adopting the resolution or within the next three months from that day.
Pursuant to § 106 sec. 2 of the Detailed Principles of KDPW Operation, at least ten days must elapse between the date of determining the right to dividend and the date of dividend payment. Pursuant to § 5 sec. 1 of the KDPW Rules, the running of these deadlines is calculated taking into account business days, excluding Saturdays. The claim for dividend payment is subject to a ten-year limitation period.


The dividend for holding the Company’s shares is paid to the shareholders on the “dividend payment date”. The dividend payment process is carried out through the depository system of the National Depository for Securities (KDPW).


The Ordinary General Meeting determines the gross dividend. Shareholders receive a net dividend, i.e. after deducting the tax due in the territory of the Republic of Poland.

Attachments

Resolution on the payment of dividend for 2017

Resolution on the payment of dividend for 2017

Your submission was succesfull

Software

Get more information
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

VCAST

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

DRAI

Get a free demo
The data administrator is Medicalgorithmics S.A. with its registered office in Warsaw (02-001) at Al. Jerozolimskie 81. The data will be processed in order to answer the query sent (legal basis: legitimate interest of the administrator), marketing (legal basis: legitimate interest of the administrator). The full text of the clause can be found on the Privacy Policy page.

Our company

About us

Our History

Management Team

Partners

Career

Work with us

Job offers

Recommend an employee

Application form